Loading…

Extracts of the cyanobacteria Microcystis flos-aquae contain potent anti-Trypanosoma compounds

To find new compounds for future development of anti- Trypanosoma drugs, we investigated cyanobacteria for secondary metabolites that kill trypanosomes, the parasites causing trypanosomiasis. Crude methanolic extracts of four cyanobacteria ( Microcystis aeruginosa EAWAG198, Microcystis flos-aquae UT...

Full description

Saved in:
Bibliographic Details
Published in:Journal of applied phycology 2024-06, Vol.36 (3), p.1279-1291
Main Authors: Agee, Jerry Tersoo, Garba, Auwalu, Chia, Mathias Ahii, Balogun, Emmanuel Oluwadare
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c270t-f9c6f0b977c32ed22079b395f5f4fe59307306a05b906929ab7dd60b9d97aea13
container_end_page 1291
container_issue 3
container_start_page 1279
container_title Journal of applied phycology
container_volume 36
creator Agee, Jerry Tersoo
Garba, Auwalu
Chia, Mathias Ahii
Balogun, Emmanuel Oluwadare
description To find new compounds for future development of anti- Trypanosoma drugs, we investigated cyanobacteria for secondary metabolites that kill trypanosomes, the parasites causing trypanosomiasis. Crude methanolic extracts of four cyanobacteria ( Microcystis aeruginosa EAWAG198, Microcystis flos-aquae UTEX 2677, Microcystis wesenbergii NIES-104, and Oscillatoria sp.) were prepared and tested on Trypanosoma brucei brucei for trypanosome-killing activity. The most active crude extract was fractionated by liquid column chromatography. Trypanocidal fractions were identified by incubating each fraction with trypanosomes and monitoring parasite death under 400× microscopic magnification. A crude extract of M. flos-aquae was also used to treat rats infected with T. b. brucei . The crude extract of M. flos-aquae exhibited the highest in vitro trypanocidal activity, with percentage inhibitions of 98.44 and 42.18% at 2.5 and 0.3125 mg mL -1 , respectively, and an IC 50 value of 0.414 mg mL -1 . The most active fraction E exhibited the highest in vitro activity against the parasite, with a percentage inhibition of 74.21 % at 0.625 mg mL -1 and an IC 50 value of 0.299 mg mL -1 . The active sub-fraction of E ( Es ) exhibited 76% inhibition at the same concentration. Interestingly, the crude extract of M. flos-aquae also suppressed parasite proliferation in treated animals and improved the weight and PCV of rats treated with dosages above 60 mg kg -1 body weight. The GC/MS profile of fraction Es revealed the presence of Cedran-diol, Ethyl-5-(furan-2-yl)-1,2-oxazole-3-carboxylate,5-amino-1-tetrazolylacetic acid, 2-amino-4-(2-methylpropanyl)-pyrimidine-5-carboxylic acid, and others. In conclusion, our findings demonstrate that cyanobacteria could be considered promising sources of lead compounds for the development of new trypanocidal drugs.
doi_str_mv 10.1007/s10811-023-03181-y
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3062781686</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3062781686</sourcerecordid><originalsourceid>FETCH-LOGICAL-c270t-f9c6f0b977c32ed22079b395f5f4fe59307306a05b906929ab7dd60b9d97aea13</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMouK7-AU8Fz9GZxDbNUZb1A1a8rFdD2ibaZTfpJinYf290BW-eBmaeZ4Z5CblEuEYAcRMRakQKjFPgWCOdjsgMS8FpiaI6JjOQDGktBZ6Ssxg3ACBrrGfkbfmZgm5TLLwt0ocp2kk73-SOCb0unvs2-HaKqY-F3fpI9X7UGfIu6d4Vg0_GpUK71NN1mIasRr_Teb4b_Oi6eE5OrN5Gc_Fb5-T1frlePNLVy8PT4m5FWyYgUSvbykIjhWg5Mx1jIGTDZWlLe2tNKTkIDpWGspFQSSZ1I7quykInhTYa-ZxcHfYOwe9HE5Pa-DG4fFJlkYkaq7rKFDtQ-akYg7FqCP1Oh0khqO8c1SFHlXNUPzmqKUv8IMUMu3cT_lb_Y30BIMB30g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3062781686</pqid></control><display><type>article</type><title>Extracts of the cyanobacteria Microcystis flos-aquae contain potent anti-Trypanosoma compounds</title><source>Springer Link</source><creator>Agee, Jerry Tersoo ; Garba, Auwalu ; Chia, Mathias Ahii ; Balogun, Emmanuel Oluwadare</creator><creatorcontrib>Agee, Jerry Tersoo ; Garba, Auwalu ; Chia, Mathias Ahii ; Balogun, Emmanuel Oluwadare</creatorcontrib><description>To find new compounds for future development of anti- Trypanosoma drugs, we investigated cyanobacteria for secondary metabolites that kill trypanosomes, the parasites causing trypanosomiasis. Crude methanolic extracts of four cyanobacteria ( Microcystis aeruginosa EAWAG198, Microcystis flos-aquae UTEX 2677, Microcystis wesenbergii NIES-104, and Oscillatoria sp.) were prepared and tested on Trypanosoma brucei brucei for trypanosome-killing activity. The most active crude extract was fractionated by liquid column chromatography. Trypanocidal fractions were identified by incubating each fraction with trypanosomes and monitoring parasite death under 400× microscopic magnification. A crude extract of M. flos-aquae was also used to treat rats infected with T. b. brucei . The crude extract of M. flos-aquae exhibited the highest in vitro trypanocidal activity, with percentage inhibitions of 98.44 and 42.18% at 2.5 and 0.3125 mg mL -1 , respectively, and an IC 50 value of 0.414 mg mL -1 . The most active fraction E exhibited the highest in vitro activity against the parasite, with a percentage inhibition of 74.21 % at 0.625 mg mL -1 and an IC 50 value of 0.299 mg mL -1 . The active sub-fraction of E ( Es ) exhibited 76% inhibition at the same concentration. Interestingly, the crude extract of M. flos-aquae also suppressed parasite proliferation in treated animals and improved the weight and PCV of rats treated with dosages above 60 mg kg -1 body weight. The GC/MS profile of fraction Es revealed the presence of Cedran-diol, Ethyl-5-(furan-2-yl)-1,2-oxazole-3-carboxylate,5-amino-1-tetrazolylacetic acid, 2-amino-4-(2-methylpropanyl)-pyrimidine-5-carboxylic acid, and others. In conclusion, our findings demonstrate that cyanobacteria could be considered promising sources of lead compounds for the development of new trypanocidal drugs.</description><identifier>ISSN: 0921-8971</identifier><identifier>EISSN: 1573-5176</identifier><identifier>DOI: 10.1007/s10811-023-03181-y</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Biomedical and Life Sciences ; Body weight ; Carboxylic acids ; Chromatography ; Column chromatography ; Cyanobacteria ; Drug development ; Drugs ; Ecology ; Freshwater &amp; Marine Ecology ; Lead compounds ; Life Sciences ; Metabolites ; Microcystis ; Microcystis flos-aquae ; Oxazole ; Parasites ; Plant Physiology ; Plant Sciences ; Protozoa ; Pyrimidines ; Secondary metabolites ; Trypanosoma ; Trypanosome ; Trypanosomiasis ; Vector-borne diseases</subject><ispartof>Journal of applied phycology, 2024-06, Vol.36 (3), p.1279-1291</ispartof><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c270t-f9c6f0b977c32ed22079b395f5f4fe59307306a05b906929ab7dd60b9d97aea13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Agee, Jerry Tersoo</creatorcontrib><creatorcontrib>Garba, Auwalu</creatorcontrib><creatorcontrib>Chia, Mathias Ahii</creatorcontrib><creatorcontrib>Balogun, Emmanuel Oluwadare</creatorcontrib><title>Extracts of the cyanobacteria Microcystis flos-aquae contain potent anti-Trypanosoma compounds</title><title>Journal of applied phycology</title><addtitle>J Appl Phycol</addtitle><description>To find new compounds for future development of anti- Trypanosoma drugs, we investigated cyanobacteria for secondary metabolites that kill trypanosomes, the parasites causing trypanosomiasis. Crude methanolic extracts of four cyanobacteria ( Microcystis aeruginosa EAWAG198, Microcystis flos-aquae UTEX 2677, Microcystis wesenbergii NIES-104, and Oscillatoria sp.) were prepared and tested on Trypanosoma brucei brucei for trypanosome-killing activity. The most active crude extract was fractionated by liquid column chromatography. Trypanocidal fractions were identified by incubating each fraction with trypanosomes and monitoring parasite death under 400× microscopic magnification. A crude extract of M. flos-aquae was also used to treat rats infected with T. b. brucei . The crude extract of M. flos-aquae exhibited the highest in vitro trypanocidal activity, with percentage inhibitions of 98.44 and 42.18% at 2.5 and 0.3125 mg mL -1 , respectively, and an IC 50 value of 0.414 mg mL -1 . The most active fraction E exhibited the highest in vitro activity against the parasite, with a percentage inhibition of 74.21 % at 0.625 mg mL -1 and an IC 50 value of 0.299 mg mL -1 . The active sub-fraction of E ( Es ) exhibited 76% inhibition at the same concentration. Interestingly, the crude extract of M. flos-aquae also suppressed parasite proliferation in treated animals and improved the weight and PCV of rats treated with dosages above 60 mg kg -1 body weight. The GC/MS profile of fraction Es revealed the presence of Cedran-diol, Ethyl-5-(furan-2-yl)-1,2-oxazole-3-carboxylate,5-amino-1-tetrazolylacetic acid, 2-amino-4-(2-methylpropanyl)-pyrimidine-5-carboxylic acid, and others. In conclusion, our findings demonstrate that cyanobacteria could be considered promising sources of lead compounds for the development of new trypanocidal drugs.</description><subject>Biomedical and Life Sciences</subject><subject>Body weight</subject><subject>Carboxylic acids</subject><subject>Chromatography</subject><subject>Column chromatography</subject><subject>Cyanobacteria</subject><subject>Drug development</subject><subject>Drugs</subject><subject>Ecology</subject><subject>Freshwater &amp; Marine Ecology</subject><subject>Lead compounds</subject><subject>Life Sciences</subject><subject>Metabolites</subject><subject>Microcystis</subject><subject>Microcystis flos-aquae</subject><subject>Oxazole</subject><subject>Parasites</subject><subject>Plant Physiology</subject><subject>Plant Sciences</subject><subject>Protozoa</subject><subject>Pyrimidines</subject><subject>Secondary metabolites</subject><subject>Trypanosoma</subject><subject>Trypanosome</subject><subject>Trypanosomiasis</subject><subject>Vector-borne diseases</subject><issn>0921-8971</issn><issn>1573-5176</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMouK7-AU8Fz9GZxDbNUZb1A1a8rFdD2ibaZTfpJinYf290BW-eBmaeZ4Z5CblEuEYAcRMRakQKjFPgWCOdjsgMS8FpiaI6JjOQDGktBZ6Ssxg3ACBrrGfkbfmZgm5TLLwt0ocp2kk73-SOCb0unvs2-HaKqY-F3fpI9X7UGfIu6d4Vg0_GpUK71NN1mIasRr_Teb4b_Oi6eE5OrN5Gc_Fb5-T1frlePNLVy8PT4m5FWyYgUSvbykIjhWg5Mx1jIGTDZWlLe2tNKTkIDpWGspFQSSZ1I7quykInhTYa-ZxcHfYOwe9HE5Pa-DG4fFJlkYkaq7rKFDtQ-akYg7FqCP1Oh0khqO8c1SFHlXNUPzmqKUv8IMUMu3cT_lb_Y30BIMB30g</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Agee, Jerry Tersoo</creator><creator>Garba, Auwalu</creator><creator>Chia, Mathias Ahii</creator><creator>Balogun, Emmanuel Oluwadare</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7TN</scope><scope>F1W</scope><scope>H95</scope><scope>L.G</scope><scope>M7N</scope></search><sort><creationdate>20240601</creationdate><title>Extracts of the cyanobacteria Microcystis flos-aquae contain potent anti-Trypanosoma compounds</title><author>Agee, Jerry Tersoo ; Garba, Auwalu ; Chia, Mathias Ahii ; Balogun, Emmanuel Oluwadare</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c270t-f9c6f0b977c32ed22079b395f5f4fe59307306a05b906929ab7dd60b9d97aea13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomedical and Life Sciences</topic><topic>Body weight</topic><topic>Carboxylic acids</topic><topic>Chromatography</topic><topic>Column chromatography</topic><topic>Cyanobacteria</topic><topic>Drug development</topic><topic>Drugs</topic><topic>Ecology</topic><topic>Freshwater &amp; Marine Ecology</topic><topic>Lead compounds</topic><topic>Life Sciences</topic><topic>Metabolites</topic><topic>Microcystis</topic><topic>Microcystis flos-aquae</topic><topic>Oxazole</topic><topic>Parasites</topic><topic>Plant Physiology</topic><topic>Plant Sciences</topic><topic>Protozoa</topic><topic>Pyrimidines</topic><topic>Secondary metabolites</topic><topic>Trypanosoma</topic><topic>Trypanosome</topic><topic>Trypanosomiasis</topic><topic>Vector-borne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Agee, Jerry Tersoo</creatorcontrib><creatorcontrib>Garba, Auwalu</creatorcontrib><creatorcontrib>Chia, Mathias Ahii</creatorcontrib><creatorcontrib>Balogun, Emmanuel Oluwadare</creatorcontrib><collection>CrossRef</collection><collection>Oceanic Abstracts</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Journal of applied phycology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Agee, Jerry Tersoo</au><au>Garba, Auwalu</au><au>Chia, Mathias Ahii</au><au>Balogun, Emmanuel Oluwadare</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extracts of the cyanobacteria Microcystis flos-aquae contain potent anti-Trypanosoma compounds</atitle><jtitle>Journal of applied phycology</jtitle><stitle>J Appl Phycol</stitle><date>2024-06-01</date><risdate>2024</risdate><volume>36</volume><issue>3</issue><spage>1279</spage><epage>1291</epage><pages>1279-1291</pages><issn>0921-8971</issn><eissn>1573-5176</eissn><abstract>To find new compounds for future development of anti- Trypanosoma drugs, we investigated cyanobacteria for secondary metabolites that kill trypanosomes, the parasites causing trypanosomiasis. Crude methanolic extracts of four cyanobacteria ( Microcystis aeruginosa EAWAG198, Microcystis flos-aquae UTEX 2677, Microcystis wesenbergii NIES-104, and Oscillatoria sp.) were prepared and tested on Trypanosoma brucei brucei for trypanosome-killing activity. The most active crude extract was fractionated by liquid column chromatography. Trypanocidal fractions were identified by incubating each fraction with trypanosomes and monitoring parasite death under 400× microscopic magnification. A crude extract of M. flos-aquae was also used to treat rats infected with T. b. brucei . The crude extract of M. flos-aquae exhibited the highest in vitro trypanocidal activity, with percentage inhibitions of 98.44 and 42.18% at 2.5 and 0.3125 mg mL -1 , respectively, and an IC 50 value of 0.414 mg mL -1 . The most active fraction E exhibited the highest in vitro activity against the parasite, with a percentage inhibition of 74.21 % at 0.625 mg mL -1 and an IC 50 value of 0.299 mg mL -1 . The active sub-fraction of E ( Es ) exhibited 76% inhibition at the same concentration. Interestingly, the crude extract of M. flos-aquae also suppressed parasite proliferation in treated animals and improved the weight and PCV of rats treated with dosages above 60 mg kg -1 body weight. The GC/MS profile of fraction Es revealed the presence of Cedran-diol, Ethyl-5-(furan-2-yl)-1,2-oxazole-3-carboxylate,5-amino-1-tetrazolylacetic acid, 2-amino-4-(2-methylpropanyl)-pyrimidine-5-carboxylic acid, and others. In conclusion, our findings demonstrate that cyanobacteria could be considered promising sources of lead compounds for the development of new trypanocidal drugs.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><doi>10.1007/s10811-023-03181-y</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0921-8971
ispartof Journal of applied phycology, 2024-06, Vol.36 (3), p.1279-1291
issn 0921-8971
1573-5176
language eng
recordid cdi_proquest_journals_3062781686
source Springer Link
subjects Biomedical and Life Sciences
Body weight
Carboxylic acids
Chromatography
Column chromatography
Cyanobacteria
Drug development
Drugs
Ecology
Freshwater & Marine Ecology
Lead compounds
Life Sciences
Metabolites
Microcystis
Microcystis flos-aquae
Oxazole
Parasites
Plant Physiology
Plant Sciences
Protozoa
Pyrimidines
Secondary metabolites
Trypanosoma
Trypanosome
Trypanosomiasis
Vector-borne diseases
title Extracts of the cyanobacteria Microcystis flos-aquae contain potent anti-Trypanosoma compounds
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T02%3A41%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extracts%20of%20the%20cyanobacteria%20Microcystis%20flos-aquae%20contain%20potent%20anti-Trypanosoma%20compounds&rft.jtitle=Journal%20of%20applied%20phycology&rft.au=Agee,%20Jerry%20Tersoo&rft.date=2024-06-01&rft.volume=36&rft.issue=3&rft.spage=1279&rft.epage=1291&rft.pages=1279-1291&rft.issn=0921-8971&rft.eissn=1573-5176&rft_id=info:doi/10.1007/s10811-023-03181-y&rft_dat=%3Cproquest_cross%3E3062781686%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c270t-f9c6f0b977c32ed22079b395f5f4fe59307306a05b906929ab7dd60b9d97aea13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3062781686&rft_id=info:pmid/&rfr_iscdi=true